Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25977774 | 0.77 | HSD17B10 (0.50) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL11227424 | 0.75 | HSD17B10 (0.60) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL29859415 | 0.75 | HSD17B10 (1.00) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL5700792 | 0.75 | HSD17B10 (0.60) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL28553719 | 0.75 | HSD17B10 (0.60) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL26788 | 0.75 | HSD17B10 (1.00) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL8044782 | 0.73 | HSD17B10 (0.95) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL8044778 | 0.73 | HSD17B10 (0.95) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL11125458 | 0.73 | HSD17B10 (0.95) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL9579917 | 0.73 | HSD17B10 (0.95) | HSD17B10TSHRSMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250084070-A1 | PROCESS FOR THE SYNTHESIS OF 5-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)FURAN-2-CARBALDEHYDE AND OF NITRONES FROM 5-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)FURAN-2-CARBALDEHYDE | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2025-03-13 | — | — | US | disclosed |
| EP-1569919-B1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2012-04-18 | — | — | EP | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084070-A1 | PROCESS FOR THE SYNTHESIS OF 5-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)FURAN-2-CARBALDEHYDE AND OF NITRONES FROM 5-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)FURAN-2-CARBALDEHYDE | MGAT1, B3GNT2, NPM1 | HSD17B10 2777/4885TSHR 4756/4885SMN1; SMN2 1070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.